Physician

Dianne Margaret Cooper, M.D.

According to 2025 Medicare claims, Dianne Cooper, M.D. (NPI: 1649232810) practices rheumatology in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is DIANNE M COOPER MD PA (NPI: 1356401301; TIN: 201986117) and primary practice location at 76309-4719. Cooper is affiliated with the Lifecare ACO LLC (ACO ID: A3644), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Cooper's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 700 traditional Medicare patients, billed 254,179 HCPCS/CPT codes, and received $4,459,624 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 10,346 prescription claims across 741 beneficiaries totaling $7,998,701 in drug costs, led by Enbrel Sureclick (Etanercept). 2018 DME data shows 16 claims. Open Payments data shows 195 records totaling $28,836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $144,151 to $4,459,624. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,411,029 to $7,998,701. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	549	9,781	$144,151
2016	549	8,732	$173,352
2017	568	13,770	$206,616
2018	590	17,757	$232,849
2019	645	32,443	$662,894
2020	709	54,909	$1,209,135
2021	754	65,276	$1,200,117
2022	794	132,155	$2,336,421
2023	713	197,806	$3,570,561
2024	700	254,179	$4,459,624

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	412	6,212	$2,411,029
2016	394	6,535	$3,085,801
2017	407	6,649	$2,832,828
2018	461	7,874	$3,527,794
2019	520	8,372	$4,034,121
2020	595	7,270	$2,177,065
2021	660	7,646	$2,252,187
2022	715	8,002	$2,628,175
2023	686	8,225	$5,400,895
2024	741	10,346	$7,998,701

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$2,264
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	16	$236
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	589	1,596	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	415	719	$59
96372	Injection of drug or substance under skin or into muscle	368	1,869	$9
J1885	Injection, ketorolac tromethamine, per 15 mg	263	2,292	$1
J1010	Injection, methylprednisolone acetate, 1 mg	206	15,202	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	238	8,428	$2,224,644
Xeljanz Xr	Tofacitinib Citrate	115	3,904	$767,242
Humira(Cf) Pen	Adalimumab	49	2,100	$606,149
Rinvoq	Upadacitinib	54	2,040	$442,113
Otezla	Apremilast	70	2,280	$377,662

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	195	$28,836	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dianne Margaret Cooper, M.D.?

Tedicare shows public-source Medicare data for Dianne Margaret Cooper, M.D. (NPI 1649232810), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dianne Margaret Cooper, M.D. have ACO affiliation data?

Dianne Margaret Cooper, M.D. is shown with ACO affiliation data for Lifecare ACO LLC (MSSP, ACO ID A3644), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Dianne Margaret Cooper, M.D.?

Dianne Margaret Cooper, M.D. is linked to DIANNE M COOPER MD PA (billing NPI 1356401301) in the available physician profile data.

Does Dianne Margaret Cooper, M.D. have Open Payments data?

Dianne Margaret Cooper, M.D. has 195 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.